首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 125 毫秒
1.
<正>1.总则 按修订的第1号生物制品规程B部分有关检定实验室的基本要求执行。(生产单应和检定实验室的基本要求) 国家质控当局应为人血和血液制品的质量检定的需要提供标准品和参考制品。在适宜情况下,这些标准应与相应的国际标准进行标校。  相似文献   

2.
目的建立第二代百日咳疫苗毒性国家标准品(简称二代毒性标准品)。方法选用百日咳疫苗生产菌株(编号CS株CMCC58003)进行发酵罐培养,将收获的百日咳菌液灭活后分装冻干后,作为第二代百日咳国家毒性标准品的候选品(简称候选毒性标准品)。以第一代百日咳疫苗毒性国家标准品为标准(简称一代毒性标准品),由4个单位协作标定候选毒性标准品,采用热加速法考察候选毒性标准品的稳定性。结果共获得检定合格的候选毒性标准品1 800支;经4个实验室协作标定,每支二代毒性标准品LPU为21,HSU为41;且稳定性良好。结论候选毒性标准品各项指标均符合要求,可作为第二代百日咳疫苗毒性国家标准品使用。  相似文献   

3.
目的 建立C1酯酶抑制剂(C1 esterase inhibitor, C1-INH)抗原含量的双抗体夹心ELISA检测方法,验证后用于C1-INH纯化工艺摸索。方法 用羊抗人C1-INH抗体作为捕获抗体,用过氧化物酶(HRP)标记的羊抗人C1-INH抗体作为检测抗体,进行棋盘滴定初步确定捕获抗体的工作质量浓度,用西门子血浆标准品进行系列稀释作为标准品经过2轮实验来确定拟合曲线和线性范围及检测抗体的工作质量浓度,用血浆标准品标定电泳C1-INH标准品(电泳纯度>92%),分析与血浆标准品的平行性来选择本方法最终使用的标准品,最终建立了C1-INH抗原含量的双抗体夹心ELISA检测方法。对此方法进行线性、准确度、精密度、加样回收率、电泳标准品稳定性的验证。将验证后的方法用于C1-INH纯化工艺的摸索及产品质量分析,并与特定蛋白检测仪的结果进行比较。结果 捕获抗体质量浓度为400.000 ng/mL,检测抗体质量浓度为400.000 ng/mL,标准曲线采用四参数方程拟合,电泳标准品的质量浓度为0.895 mg/mL,血浆标准品作为本方法标准品;标准曲线的线性范围为1.560~100...  相似文献   

4.
以短小芽孢杆菌为检定菌,比较了培养基原料对抑菌圈的影响,进行了检定菌的分离和敏感活性测定,标准曲线的可倍限率检测;一剂量和二剂量法的可靠性试验;样品效价测定和统计分析,确认我们建立的硫酸西梭霉素的生测方法是准确、可行的。*p<0.001),试品间和偏离平行不显著(*p>0.05),可倍限率小于5%,本实验成立。按n次实验结果合并计算,处理2#、3#两批样品的实验结果,见表4。经统计分析,2#样品标定效价为629ug/mg,可倍限率4.19%。3#样品标定效价579ug/mg,可倍限率3.71%。3结论3.1硫酸西梭霉素生物效价测定,美国药典[1]以表皮葡萄球菌作检定菌。我们用短小芽孢杆菌作检定菌,抑菌圈清晰,菌液易于保藏,测定结果准确,复现性强。因此,短小芽孢杆菌可作为硫酸西梭霉素的检定菌,培养时间14~16小时,培养温度35~37℃。3.2采用标准曲线法和二剂量法进行生物效价测定。前者标准品溶液校正点为5ug/ml,后者标准品溶液浓度分别为10ug/ml,5ug/ml,剂距比2:1。3.3试验结果表明,培养基的原料直接影响检定菌的生长和样品扩散,从而影响抑菌圈的大小和清晰程度。蛋白陈和琼脂的质量尤为重量。?  相似文献   

5.
收集正常人、HIV感染者和疑似感染者血浆以及HIV-1病毒培养裂解液,对其进行HIV抗体、HIVP24抗原、HCV抗体和HBsAg检测,对HIVP24抗原阳性者进行HIVRNA检测,并对部分样品进行基因分型。以NIBSCP24抗原标准品的系列稀释样品作为线性灵敏度参考品。经过实验筛选出20份阴性参考品,10份阳性参考品,10份线性灵敏度参考品,2份精密性参考品,共同组成HIV-1P24抗原国家参考品,经多家不同的试剂进行标定,制定了相应的标准。稳定性研究结果表明,反复冻融三次对该参考品的稳定性没有影响。由此,初步建立了HIV-1P24抗原国家参考品,该参考品将对HIV-1P24抗原、HIV抗体/P24抗原联合检测试剂的质量控制提供重要依据。  相似文献   

6.
HIV-1 P24抗原国家参考品的研制   总被引:4,自引:0,他引:4  
收集正常人、HIV感染者和疑似感染者血浆以及HIV-1病毒培养裂解液,对其进行HIV抗体、HIV P24抗原、HCV抗体和HBsAg检测,对HIV P 24抗原阳性者进行HIVRNA检测,并对部分样品进行基因分型.以NIBSCP 24抗原标准品的系列稀释样品作为线性灵敏度参考品.经过实验筛选出20份阴性参考品,10份阳性参考品,10份线性灵敏度参考品,2份精密性参考品,共同组成HIV-1 P24抗原国家参考品,经多家不同的试剂进行标定,制定了相应的标准.稳定性研究结果表明,反复冻融三次对该参考品的稳定性没有影响.由此,初步建立了HIV-1 P24抗原国家参考品,该参考品将对HIV-1 P24抗原、HIV抗体/P 24抗原联合检测试剂的质量控制提供重要依据.  相似文献   

7.
系统研究了通过霍乱毒素B亚基与HCV的4个抗原决定簇进行基因融合所表达的12种融合蛋白中HCV抗原决定簇的反应原性,探索了以融合蛋白为抗原,进行抗-HCV检测的途径。结果表明,多数融合蛋白中HCV抗原决定簇均能与对应的HCV抗体结合。以融合蛋白95082为抗原研制的抗-HCV ELISA试剂检测122名献血员血清,结果与美国雅培公司抗-HCV ELISA试剂检测的结果完全一致,经药品生物制品检定所检定,其特异性、灵敏度、精密性及稳定性均达到国家卫生部抗-HCV ELISA试剂的暂行检定标准。  相似文献   

8.
建立了一种紫外-可见分光光度检测法,可以快速、简便、稳定地测定重组碱性成纤维细胞生长因子的游离巯基含量。将检测试剂、标准品及待测样品一起反应后,在412 nm波长处读取OD值,以标准品浓度为横坐标,以吸光值为纵坐标,绘制标准曲线,根据标准曲线计算待测样品中游离巯基含量;同时对该方法进行了方法学验证。结果表明:该方法专属性强,游离巯基含量测定范围为20~80μg/ml,线性相关系数在0.999以上,回收率范围为91.7%~107.4%;而且该法精密度较好,精密度的变异系数范围为5%~8%。测得的分子表面和总游离巯基含量与理论一致,可用于蛋白质游离巯基检测,以监测分子结构的正确性与均一性。  相似文献   

9.
完善的实验室质量体系是保证检测结果可靠性的关键。本文主要介绍实验室质量体系建设的基本要求,并针对生物检定实验室的特点,结合世界卫生组织疫苗质量管理实验室质量体系培训的内容,介绍生物检定实验室质量体系建设的考虑要点。主要内容涉及人员与培训、生物安全、仪器设备的校准、验证和维护、实验方法验证、实验结果超出质量标准规定的处理、标准品管理、实验室内部审核与年度审评等。  相似文献   

10.
【目的】针对不产氧光合细菌(APB)类胡萝卜素(Car)标准品缺乏的问题,以替代标准品实现螺菌黄质系多种Car组分同步、快速、准确的定量分析。【方法】以沼泽红假单胞菌CQV97为材料,采用吸收光谱、薄层层析和HPLC等方法制备螺菌黄质系Car标准品;以柠檬黄和番茄红素为替代标准品,采用HPLC法,建立了螺菌黄质系Car多组分的定量方法。【结果】制备的6种Car标准品纯度达95%以上。确定了Car的HPLC分析条件,以Car标准品为对照,得到了螺菌黄质系6种Car组分的定性HPLC指纹图谱。在选择的HPLC条件下,测定了6种Car标准品和2种替代标准品的标准曲线,确立了2种替代标准品分别与6种Car标准品之间的定量校正函数关系,并用于实际样品YL28和CQV97菌株的Car定量分析。采用Car标准品法测定的6种Car含量的RSD小于1.5%、回收率在96%-104%,替代标准品法与Car标准品法测定结果吻合,其相对误差小于0.1%。【结论】通过替代标准品校正函数关系,建立了2种准确定量分析螺菌黄质系Car多组分的方法。替代标准品柠檬黄和番茄红素均能准确地传递待测Car的量值关系,实现了螺菌黄质系6种Car的同步、快速、准确的定量分析,弥补了现有Car组分相对定量方法的不足。讨论了替代标准品法校正因子适用范围的局限性,提出了校正函数关系的思路和方法。这为全面实现APB球形烯系、奥氏酮系等其它Car的快速、准确定量分析提供了借鉴和参考。  相似文献   

11.
A total of 218 batches of blood preparations produced from different raw materials have been studied by means of enzyme immunoassay kits (Abbott Laboratories, USA). The assays have revealed that the preparations under study are nonstandard with respect to the content and isolation rate of HBsAg, the marker of hepatitis B virus. These data necessitate search for the ways of improving the quality of blood preparations.  相似文献   

12.
目的为了对人巨细胞病毒(Human cytomegalovirus,HCMV)IgM抗体检测试剂进行统一评价,研制HCMVIgM抗体国家参考品,用于控制试剂盒的质量。方法收集正常人与感染者的标本,采用多实验室联合标定的方法确认参考品的试验结果,并经一系列的破坏条件进行稳定性和均匀性考核。结果考核的敏感性和准确性符合国家参考品的要求。结论该参考品能用于临床检测试剂的质量控制。  相似文献   

13.
目的:建立丙型肝炎病毒(rmv)抗体化学发光免疫检测方法,并分析其临床应用价值。方法:应用基因工程重组的HCV抗原包被微孔板,以辣根过氧化物酶标记的羊抗人IgG为二抗,并结合鲁米诺化学发光底物系统,建立HCV抗体化学发光免疫检测方法;应用HCV抗体诊断试剂国家参考品分析所建立方法的特异性、灵敏度、稳定性和精密性,并-9北京万泰公司的ELISA试剂盒同时检测临床血清样本350份,比较检测结果。结果:检测结果符合国家参考品质量标准。批内变异系数5.1%。6.6%,批间变异系数9-5%;试剂盒置37℃考核3d,其稳定性良好;与万泰公司的ELISA检测结果对照,阳性符合率分别为99.0%,阴性符合率分别为100%,总符合率为99.4%;Kappa值为0.986,一致性强度最强。结论:建立了特异、敏感和稳定的HCV抗体化学发光免疫检测方法,适用于HCV感染的批量筛查,具有较大的临床应用价值。  相似文献   

14.
There has recently been a proliferation of commercial kits available for apoproteins A-I and B. Since reference procedures for apoproteins have not yet been established we have elected to compare apoprotein kit methods with highly standardized apoprotein B and A-I radioimmunoassays developed at the Northwest Lipid Research Center. Commercial radial immunodiffusion kits for apoproteins A-I and B were obtained from three separate companies, Calbiochem, Daiichi Pure Chemicals, and Tago, and a commercial radioimmunoassay kit for apoprotein A-I was obtained from Ventrex Laboratories. Considerable differences were observed between the commercial kit methods and the Northwest Lipid Research radioimmunoassay methods. Some of the differences between methods were related to the assigned value of the reference materials. Other differences between methods were clearly method-dependent.  相似文献   

15.
Several commercial and "in-house" assays have been developed for the detection of antibodies to hepatitis E virus, a major causative agent of enterically transmitted non-A non-B hepatitis. As these kits contain a variety of synthetic peptides or recombinant proteins, greater standardisation is required. A collaborative study was therefore carried out to assess the suitability of a freeze dried preparation designated 95/584 to serve as a reference reagent for hepatitis E virus serum IgG. Preparation 95/584, which is a serum from a previously infected individual, was assayed along with four coded samples, one of which D, was a coded duplicate of 95/584, and three individual sera, coded A, B and C. These preparations were sent to seven laboratories in five countries who tested them in eight different enzyme immunoassays. In most laboratories the coded duplicate gave a mean potency of within 20% of the candidate reference reagent despite the wide range of assays used. However, the potencies of the coded samples which were from different individuals gave somewhat variable potencies relative to the candidate reference reagent. This is not surprising as each sample will have varying proportions of antibodies against individual viral proteins and result in the variation in results observed. Nevertheless, this material will be of use in the standardisation of diagnostic tests for use in sero-prevalence studies and for assessing immunity. Preparation 95/584 was found to be suitable to serve as a reference reagent for hepatitis E serum IgG and has been established as an interim Reference Reagent for Human anti-hepatitis E serum. Each ampoule contains 50 Units per ampoule.  相似文献   

16.
An interlaboratory quality control scheme has been established in Britain by the British Committee for Standards in Haematology. In the first instance this has been confined to haemoglobin, red blood cell count, and packed cell volume. The materials which have been circulated include whole blood, stabilized red cell preparations, lysates, cyanmethaemoglobin solutions, and cyanmethaemoglobin reference preparations. The first two trials have been completed, and there are implications for instrument calibration, dilution techniques, and the use of standards. Periodic interlaboratory trials, at a national level, in conjunction with regular individual intralaboratory quality control procedures, are necessary in order to achieve acceptable levels of accuracy and precision.  相似文献   

17.
The passive hemagglutination test (Sero-Test CCB) for the detection of hepatitis B surface antigen (HBsAg) has been developed. The comparative study of the sensitivity of Sero-Test CCB, the passive hemagglutination test Hepanostikon (developed by Organon, the Netherlands) and the radioimmunoassay (with the use of an experimental assay kit provided by the Institute of Vaccines in Dessau, GDR) has been carried out by the determination of HBsAg in 100 coded sera from viral hepatitis patients and hepatitis virus carriers. Both passive hemagglutination tests (Sero-Test CCB and Hepanostikon) have yielded coinciding results (r = 0.90). The sensitivity of Sero-Test CCB has been found to exceed that achieved with the use of electrophoretic techniques 30-150 times, though it is 8 times lower than the sensitivity of the radioimmunoassay. The test kits Sero-Test CCB HBsAg are used for the examination of donor blood and for the survey of groups of persons subjected to a high risk of contacting hepatitis B infection in hemodialysis and transplantation centers, surgical wards, etc.  相似文献   

18.
Donors screened by medical social history interview negative for high risk behavior or communicable disease history, but subsequently exhibiting reactive serological markers, emphasize importance of duel safe guarding factors for determining donor suitability. This report examines a relationship between two immunoabsorption assay tests, hepatitis B core (HBc) antibody, a required food and drug administration (FDA) test, and hepatitis B antibody (anti HBs), non-required test. Reactive serology results, 129 cases, 3,581 donors (2008–2012) for HBc as the only initially positive serological marker were subjected to anti HBs testing in this history pre-screened donor population. Enzyme linked immunoabsorption assay kits hepatitis B, core and antibody, were used in this study. All samples were initially tested for human immunodeficiency virus, hepatitis B, and hepatitis C, utilizing nucleic acid testing and antigen antibody immunoabsorption assay. Testing was performed by a FDA-registered CLEA-certified reference laboratory. Samples were deceased donor blood samples and a limited number of pre-mortem samples, separated, stored and analyzed according to manufacturer recommendation and FDA regulations. 129 reactive HBc only samples, were subsequently tested for anti HBs. Of these 129, 94 were found to be reactive for anti HBs. This represented 72 % of samples tested for antibody, a higher percentage than anticipated for a medical history negative, low risk population.  相似文献   

19.
NAT testing has become an integral part in the safety programs of both plasma fractionators and transfusion services. NAT testing for HCV RNA is now mandatory for plasma fractionators in Europe and for transfusion services in Germany and Austria. Before NAT testing of plasma could become mandatory, a defined environment had to be created to allow comparison of different NAT procedures. To create such an environment, international virus standards, as well as guidelines for validation, assessment of robustness, and quality assurance of NAT have been released. This paper is a critical review of currently available standards and national reference preparations, detection limits, and national regulations of NAT in view of the specific nature of NAT.  相似文献   

20.
Several methods for the quantification of human anti-HBs, an antibody to hepatitis B surface antigen (HBsAg), have been developed based on enzyme reaction, chemiluminescence, fluorescence, and radioactivity for application to human serum or plasma. Commercial anti-HBs immunoassay kits use a sandwich method in which a bridge is formed by the anti-HBs between a HBsAg immobilized solid matrix and the labeled HBsAg. However, this direct sandwich enzyme-linked immunosorbent assay (ELISA) is insufficient to accurately evaluate the activity of the human monoclonal anti-HBs, GC1102. As an alternative, we developed an indirect anti-HBs ELISA (anti-HBs qELISA_v.1) that improved detection of anti-HBs. In this current study, we further optimized this indirect method to minimize nonspecific binding of human serum, by employing incubation buffers containing animal serum, Tween 20, skim milk, and a low pH washing buffer. This new and improved method, termed anti-HBs qELISA_v.2, showed accurate quantification of plasma-derived hepatitis B immune globulin (HBIG) and was comparable to results obtained with commercial ELISA (r?=?0.93) and RIA (r?=?0.85) kits. Further, the GC1102 in human serum could be precisely measured using the anti-HBs qELISA_v.2 without limitations of nonspecific binding.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号